A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 13, 2010

Study Completion Date

January 13, 2010

Conditions
Colorectal Cancer
Interventions
DRUG

Amifostine

Patients should be treated with oxaliplatin-based chemotherapy in combination with amifostine for 12 cycles, or until unacceptable toxicity is observed or disease progression

Trial Locations (1)

45267

University of Cincinnati, Cincinnati

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

MedImmune LLC

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

lead

University of Cincinnati

OTHER